Pfizer Comes Back Into Buy Consideration

Pfizer (PFE) has been a strong contributor to our portfolios in the past and has come back on the radar screen when it dipped briefly below the 80%FV floor.

It now stands just a hair above this floor at 80.7%FV. EPS are expected to improve over the next 12 months and provides a dividend of 4.06%.

Pfizer is a Core stock. You can see our chart at: https://www.tradingview.com/chart/0AzDtHWc/.

By | 2016-02-19T08:11:11+00:00 February 19th, 2016|Categories: Money Basics|0 Comments

About the Author:

Articles attributed to "Guest Contributor" are written by former employees or invited guests. Contents are for your consideration only The opinions expressed herein are those of the authors and do not necessarily represent the views of Charter Trust Company. Nothing contained in this communication should be construed as investment advice.

Leave A Comment